05895nam a22005655i 4500 978-981-96-0259-9 DE-He213 20251030114932.0 cr nn 008mamaa 250127s2024 si | s |||| 0|eng d 9789819602599 978-981-96-0259-9 10.1007/978-981-96-0259-9 doi RC321-580 PSAN bicssc SCI089000 bisacsh PSAN thema Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease [electronic resource] / edited by Ghulam Md Ashraf, Ali T. Zari, Md. Habibur Rahman, Chenmala Karthika, Veera Venkata Satyanarayana Reddy Karri. 1st ed. 2024. Singapore : Springer Nature Singapore : Imprint: Springer, 2024. XVIII, 430 p. 42 illus., 37 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Part 1. Basic Concepts of neurodegeneration and Alzheimer’s disorder -- Basic anatomy and physiology of the central nervous system -- Neurodegenerative disorders: Types, Classification, and basic concepts -- Alzheimer’s disorder: epidemiology, etiology, risk factors, future predictions -- Pathophysiology and underlying mechanisms: pathways to Alzheimer’s plaque formation -- Correlation of Alzheimer’s and other psychologic and non-psychologic conditions -- Part 2. Current scenario of Alzheimer’s disorder -- Hurdles & strategies in treating Alzheimer’s disorder -- Diagnosis of Alzheimer’s, types of plaques and their detection, imaging techniques, and other tests -- Current drugs used: classification, pharmacology -- Approved drug regimens, combinations, and delivery systems for Alzheimer’s disorder -- Traditional therapies for Alzheimer’s disorder -- Part 3. Novel therapeutic approaches to Alzheimer’s Therapy -- Nanotechnology in Alzheimer’s -- Targeted drug delivery: amyloid beta targeting drugs, immunotherapy, anti-tau, and aggregation inhibitor, microtubule-stabilizing, and neuro-inflammation modulation -- Neuroprotective approach, microbiome therapy, and overcoming insulin resistance in the brain -- Nonpharmacological approaches: Brain stimulations, vagus nerve stimulation, magnetic and electrical transcranial stimulations -- Part 4. Alzheimer’s drug development -- Understanding the potential targets of Alzheimer’s disorder -- Upcoming nano and conventional drug delivery strategies for Alzheimer’s disorder -- Animal models and ethics in the testing of drugs for Alzheimer’s disorder -- Regulatory guidelines and approval process for drugs and formulations for AD -- Part 5. Future of Alzheimer’s disorder -- Prevention and reduction of risk of AD: lifestyle changes, dietary changes, supplements, etc -- Natural medicines (phytoconstituents) and probiotics as the future of Alzheimer’s Disorder -- Future barriers and possible solutions with recent advances in the field of Alzheimer’s disease. This book is a comprehensive guide to the pathology, underlying mechanisms, and treatment options for Alzheimer's disease (AD). The book starts with an introduction to the basic anatomy and physiology of the central nervous system, followed by an overview of the types, classifications, and basic concepts of neurodegenerative disorders. The epidemiology, etiology, risk factors, and future predictions of AD have been covered in detail. The book then delves into the pathophysiology and underlying mechanisms of plaque formation and explores the correlation of AD with other psychological and non-psychological conditions. The chapters also explore the diagnosis of AD, including types of plaques and their detection, imaging techniques, and other tests. The book also covers traditional therapies for AD and explores the potential application of nanotechnology in AD treatment. The book also covers animal models and ethics in the testing of drugs for AD, regulatory guidelines, and the approval process for drugs and formulations for AD. Prevention and reduction of AD risk are explored, including lifestyle changes, dietary changes, supplements, natural medicines (phytoconstituents), and probiotics as the future of AD. The book concludes with a discussion of future barriers and possible solutions with recent advances in the field of AD. This book is an essential guide for students, researchers, and healthcare professionals interested in Alzheimer's disease research. Neurosciences. 68384 Neuropharmacology. 78368 Nervous system Diseases. 64036 Neuroscience. 68386 Neuropharmacology. 78368 Neurological Disorders. 74042 Ashraf, Ghulam Md. editor. edt http://id.loc.gov/vocabulary/relators/edt 74160 Zari, Ali T. editor. edt http://id.loc.gov/vocabulary/relators/edt 90499 Rahman, Md. Habibur. editor. edt http://id.loc.gov/vocabulary/relators/edt 90500 Karthika, Chenmala. editor. edt http://id.loc.gov/vocabulary/relators/edt 90501 Karri, Veera Venkata Satyanarayana Reddy. editor. edt http://id.loc.gov/vocabulary/relators/edt 90502 SpringerLink (Online service) Springer Nature eBook Printed edition: 9789819602582 Printed edition: 9789819602605 Printed edition: 9789819602612 https://doi.org/10.1007/978-981-96-0259-9 ZDB-2-SME ZDB-2-SXM 66541 66541